44206-300Level 3
Rhophylac (HUMAN RHO(D) IMMUNE GLOBULIN)
**Product type:** Plasma Derivative
**Active ingredient:** HUMAN RHO(D) IMMUNE GLOBULIN
**Strength:** 1500 [iU]/2mL
**Dosage form:** Solution
**Route:** Intramuscular; Intravenous
**Labeler:** CSL Behring AG
**Marketing category:** BLA (BLA125070)
**Pharmacologic class:** Endogenous Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]
GET
/api/v1/systems/ndc_fda/nodes/44206-300Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.